# The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery

> **NCT05714007** · PHASE4 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Perioperative Anemia
- Surgery
- Spinal Deformity
- Adult

## Interventions

- **DRUG:** Ferric derisomaltose
- **DRUG:** Ferrous succinate

## Key facts

- **NCT ID:** NCT05714007
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-31
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05714007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05714007, "The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05714007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*